Heron Therapeutics Enters into Cooperation Agreement with Rubric Capital and Velan Capital Feb 22, 2023 09:00AM
Form SC 13G/A AVADEL PHARMACEUTICALS Filed by: Broadfin Capital, LLC Feb 13, 2020 05:27PM
Form SC 13G/A AVADEL PHARMACEUTICALS Filed by: Broadfin Capital, LLC Oct 7, 2019 06:25AM
Form SC 13D/A AVADEL PHARMACEUTICALS Filed by: Broadfin Capital, LLC Oct 4, 2019 04:18PM
Avadel Pharma (AVDL) Reports Resignation of Kevin Kotler from Board Oct 4, 2019 04:09PM


Oct 4, 2019 04:05PM Avadel Announces Resignation of Kevin Kotler from Board of Directors
Aug 9, 2019 04:08PM Form 4 AVADEL PHARMACEUTICALS For: Aug 07 Filed by: Broadfin Capital, LLC
Jan 3, 2019 08:43AM Avadel Pharma (AVDL) Reports Resignation of CEO Michael S. Anderson, Appoints COO Gregory Divis as Interim CEO; Names Geoffrey Glass as Board Chair & Eric Ende to Board
Jan 3, 2019 08:30AM Avadel Pharmaceuticals Announces Changes to Management Team and Board of Directors
Dec 13, 2018 04:04PM Form 3 AVADEL PHARMACEUTICALS For: Dec 07 Filed by: Broadfin Capital, LLC
Dec 11, 2018 05:01PM Form SC 13D AVADEL PHARMACEUTICALS Filed by: Broadfin Capital, LLC
Dec 11, 2018 08:31AM Avadel Pharma (AVDL) Announces Kevin Kotler to Board
Dec 11, 2018 08:30AM Avadel Pharmaceuticals Appoints Kevin Kotler to the Company’s Board of Directors
Feb 13, 2018 04:28PM Form SC 13G/A AVADEL PHARMACEUTICALS Filed by: Broadfin Capital, LLC
Jan 6, 2017 10:17AM Form SC 13G/A AVADEL PHARMACEUTICALS Filed by: Broadfin Capital, LLC
Jan 6, 2017 10:08AM Form SC 13G AVADEL PHARMACEUTICALS Filed by: Broadfin Capital, LLC